Women's Hormone Health: What Labs to Run and When

Here's a frustrating truth: most women who ask their doctor for hormone testing get a single blood draw, run at a random point in their cycle, compared against reference ranges so wide they could include both thriving and suffering in the same "normal" bracket. The result? "Your labs look fine." Meanwhile, the fatigue, the mood swings, the weight that won't budge, the sleep that disappeared — all of it persists.

Female hormones are cyclical by design. Testing them requires understanding that cycle — when to draw, what to draw, and what the numbers actually mean in context. This guide breaks down the entire framework.

"The number one mistake I see in women's hormone care is timing. A progesterone level drawn on day 5 of the cycle tells you almost nothing. Drawn on day 21, it tells you everything. Timing isn't a detail — it's the foundation."

— Dr. Elena Marquez, Tuya Care

Why Cycle Day Matters

A woman's hormonal landscape shifts dramatically across her menstrual cycle. Estradiol, progesterone, LH, and FSH each peak and trough at different points. Drawing blood on the wrong day doesn't just reduce accuracy — it can produce genuinely misleading results that lead to incorrect diagnoses or unnecessary interventions.

Day 3 Testing (Follicular Phase Baseline)

Day 3 of the cycle (counting from the first day of full menstrual flow) is the standard window for baseline hormonal assessment. At this point, the ovaries are in their "resting" state, providing a clean snapshot of your hormonal foundation.

What to draw on Day 3:

• FSH (follicle-stimulating hormone): Elevated FSH on day 3 suggests diminished ovarian reserve — the ovaries are working harder to stimulate follicle development.
• Estradiol (E2): Should be relatively low on day 3. Elevated baseline estradiol can indicate an ovarian cyst or declining ovarian function.
• LH (luteinizing hormone): The LH-to-FSH ratio helps screen for PCOS (a ratio greater than 2:1 is suggestive).
• AMH (anti-Mullerian hormone): Can be drawn any day, but often bundled with day 3 labs. Reflects ovarian reserve.

Day 21 Testing (Luteal Phase Confirmation)

Day 21 — or more precisely, 7 days post-ovulation — is when progesterone should be at its peak. This is the only time a progesterone level meaningfully confirms whether ovulation occurred and whether the corpus luteum is producing adequate hormonal support.

What to draw on Day 21:

• Progesterone: Levels above 10 ng/mL confirm robust ovulation. Between 5-10 suggests weak ovulation. Below 5 raises questions about anovulation or luteal phase deficiency.
• Estradiol: A second estradiol reading gives you the full picture of estrogen-progesterone balance.

"I always tell patients: if your cycle is longer than 28 days, your 'day 21' isn't day 21. We need to count backward from your expected period. A woman with a 35-day cycle should test around day 28. Precision here changes everything."

— Dr. Elena Marquez, Tuya Care

The Core Hormone Panel

Beyond the cycle-specific draws, a comprehensive women's hormone panel should include markers that standard bloodwork often overlooks. Dr. Marquez recommends the following as a baseline for any woman presenting with hormonal symptoms:

• Estradiol (E2): The primary estrogen. Drives menstrual cycle regulation, bone density, cardiovascular health, and cognitive function.
• Progesterone: The calming counterbalance to estrogen. Essential for sleep, mood stability, and uterine health.
• Total and free testosterone: Often overlooked in women — but critical for libido, energy, muscle maintenance, and motivation. Low testosterone in women is dramatically underdiagnosed.
• DHEA-S: An adrenal androgen precursor. Low DHEA-S often signals adrenal fatigue and cortisol dysregulation.
• Cortisol (AM fasting): The stress hormone. A single morning cortisol isn't perfect, but it's a useful screening tool. Ideally paired with a 4-point salivary or urinary cortisol curve.
• Full thyroid panel (TSH, free T3, free T4, TPO antibodies, reverse T3): Thyroid dysfunction mimics and amplifies hormonal imbalances. A TSH alone is insufficient.
• Fasting insulin: Insulin resistance is a root driver of PCOS, weight gain, and hormonal disruption. A fasting glucose alone misses early insulin resistance entirely.
• SHBG (sex hormone-binding globulin): SHBG binds testosterone and estradiol, controlling how much is biologically available. Low SHBG (common with insulin resistance) means more free androgens — a key mechanism in PCOS.

Perimenopause vs. Menopause Testing

Perimenopause — the 2-10 year transition before menopause — is notoriously difficult to diagnose by labs alone, because hormones fluctuate wildly during this phase. A single blood draw might catch a perfectly normal estradiol level one week and a menopausal-range level the next.

Perimenopause clues in labwork:

• FSH that bounces between normal and elevated (above 25 mIU/mL) on repeated tests
• Shortened menstrual cycles (less than 25 days) — often the earliest measurable sign
• Declining progesterone with relatively preserved estradiol (the "estrogen dominance" pattern)
• Erratic estradiol levels across multiple draws

Confirmed menopause: Defined as 12 consecutive months without a period. Lab confirmation typically shows FSH consistently above 30-40 mIU/mL and estradiol below 30 pg/mL.

"Perimenopause is a clinical diagnosis supported by labs — not a lab diagnosis alone. I listen to the symptoms first. If a 43-year-old woman tells me her sleep vanished, her periods changed, and her anxiety appeared out of nowhere, I believe her. The labs help me quantify what she's already telling me."

— Dr. Elena Marquez, Tuya Care

The PCOS Panel

Polycystic ovary syndrome affects an estimated 8-13% of reproductive-age women, yet remains underdiagnosed. A targeted PCOS panel goes beyond the basics:

• Total and free testosterone: Elevated in most PCOS presentations
• DHEA-S: Helps distinguish ovarian vs. adrenal androgen excess
• Fasting insulin + fasting glucose: Calculate HOMA-IR to assess insulin resistance (the metabolic engine driving most PCOS)
• SHBG: Typically low in PCOS, amplifying androgen availability
• LH:FSH ratio: Greater than 2:1 supports diagnosis (though not required by Rotterdam criteria)
• 17-hydroxyprogesterone: Rules out non-classical congenital adrenal hyperplasia, which mimics PCOS
• AMH: Often elevated in PCOS due to increased follicle count
• Lipid panel and HbA1c: Metabolic screening given the cardiovascular risks associated with PCOS

The Fertility Panel

For women actively trying to conceive or planning for future fertility, the panel expands to include ovarian reserve and ovulatory function markers:

• AMH: The best single marker of ovarian reserve. Declines with age but varies significantly between individuals.
• Day 3 FSH and estradiol: Elevated FSH (above 10 mIU/mL) with elevated estradiol (above 60-80 pg/mL) suggests diminished reserve.
• Day 21 progesterone: Confirms ovulation quality.
• Prolactin: Elevated prolactin suppresses ovulation. Should be screened in any woman with irregular cycles or anovulation.
• TSH: Thyroid dysfunction is a leading cause of subfertility. Optimal TSH for conception is 1.0-2.5 mIU/L (tighter than the standard reference range).
• Vitamin D: Low vitamin D is associated with reduced fertility outcomes and higher miscarriage risk.

When to Test: Symptoms That Warrant a Full Panel

Not every woman needs comprehensive hormone testing. But the following symptoms should prompt a thorough evaluation rather than a "wait and see" approach:

• Persistent fatigue that doesn't respond to sleep optimization
• Menstrual cycle changes — shorter, longer, heavier, lighter, or absent
• New or worsening anxiety, depression, or mood instability
• Unexplained weight gain, particularly around the midsection
• Sleep disruption — difficulty falling asleep, staying asleep, or waking unrefreshed
• Low libido or vaginal dryness
• Hair loss, acne, or excess facial/body hair
• Brain fog, difficulty concentrating, memory lapses
• Night sweats or hot flashes at any age
• Difficulty conceiving after 6+ months of trying (12 months if under 35)

Optimal vs. Reference Ranges: The Gap That Matters

Standard lab reference ranges are derived from the general population — including people who are symptomatic, medicated, and metabolically unwell. "Normal" on a lab report simply means you fall within the range of 95% of the population. It says nothing about whether that level is optimal for you.

Dr. Marquez uses tighter, functional ranges:

• TSH: Standard range 0.5-4.5 mIU/L. Optimal: 1.0-2.0 mIU/L.
• Free T3: Standard range 2.0-4.4 pg/mL. Optimal: 3.0-4.0 pg/mL.
• Fasting insulin: Standard range 2.6-24.9 uIU/mL. Optimal: below 7 uIU/mL.
• Vitamin D: Standard range 30-100 ng/mL. Optimal: 50-80 ng/mL.
• DHEA-S: Varies by age, but Dr. Marquez aims for the upper third of the age-adjusted range.

"The difference between 'normal' and 'optimal' is the difference between surviving and thriving. A TSH of 4.0 is technically normal. But I've seen hundreds of women with a TSH of 4.0 who are exhausted, gaining weight, and losing hair. Treat the patient, not the reference range."

— Dr. Elena Marquez, Tuya Care

DUTCH Test vs. Serum: When to Use Each

The DUTCH (Dried Urine Test for Comprehensive Hormones) test has become a staple in functional and integrative medicine. It offers something serum testing cannot: a view of hormone metabolites — how your body processes and clears hormones, not just how much is circulating.

When Serum Testing Is Sufficient

• Initial screening and baseline assessment
• Monitoring hormone replacement therapy (HRT) dosing
• Thyroid and insulin assessment
• Fertility workups (serum remains the standard)

When to Add a DUTCH Test

• Estrogen metabolism questions: The DUTCH reveals whether you metabolize estrogen down protective (2-OH) or potentially harmful (4-OH, 16-OH) pathways — crucial for breast cancer risk assessment.
• Cortisol pattern analysis: A 4-point cortisol curve reveals adrenal rhythm dysregulation that a single morning cortisol misses.
• Androgen metabolism: Differentiates between testosterone production and 5-alpha reductase activity (relevant for hair loss and acne).
• Melatonin assessment: Included in the DUTCH and relevant for sleep disorders.
• Patients on HRT: Tracks how supplemented hormones are being metabolized, ensuring safe estrogen clearance.

The limitation: DUTCH testing is more expensive (typically $300-400 out of pocket) and requires proper sample collection across a specific timeframe. It's a second-line tool, not a screening tool.

How HRT Changes Your Monitoring Needs

Once a woman starts hormone replacement therapy, the monitoring cadence and markers shift. Dr. Marquez recommends:

First 3 Months on HRT

• Serum estradiol and progesterone at 6-8 weeks to confirm adequate levels
• Symptom assessment at 4, 8, and 12 weeks
• Liver function tests if using oral estrogen (transdermal bypasses first-pass metabolism)

Ongoing HRT Monitoring (Every 6-12 Months)

• Estradiol, progesterone, testosterone (total and free)
• SHBG — tracks estrogen's effect on binding proteins
• CBC and metabolic panel
• Lipid panel — estrogen influences HDL, LDL, and triglycerides
• Annual DUTCH test to monitor estrogen metabolism pathways

Retesting Frequency for Non-HRT Patients

For women not on HRT, Dr. Marquez recommends comprehensive hormone panels every 6-12 months during symptomatic periods, and annually as a wellness baseline after age 35. Any significant life change — new stress, weight change, medication change, or symptom onset — warrants retesting.

"Hormones are not a 'test once and forget' situation. They are dynamic, responsive, and constantly shifting. The practitioners who get the best outcomes for their female patients are the ones who retest strategically and adjust continuously."

— Dr. Elena Marquez, Tuya Care

The Bottom Line

Women's hormone testing is both an art and a science. The science is in the markers — knowing what to draw and when. The art is in the interpretation — understanding that a single number on a page means nothing without context. Cycle day. Symptoms. Age. History. Goals.

If you've been told your hormones are "normal" but you don't feel normal, the problem may not be your hormones. It may be how — and when — they were tested. The right panel, drawn at the right time, interpreted through the right lens, can be the difference between years of suffering and a clear path forward.